Hematuria laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:


A more complete evaluation would include the following:
A more complete evaluation would include the following:
* C3 levels
* [[Complement component 3 | C3]] levels
* Red blood cells casts
* [[Urinary casts#Cellular casts | Red blood cells casts]]
* Cyroglobulins
* [[Cryoglobulins]]
* Hepatitis C antibodies
* Presence of [[Hepatitis C laboratory tests | Hepatitis C antibodies]]
* Anti-glomerular basement membranes (GBM)
* Anti-glomerular basement membranes (GBM)
* Antinuclear anitbodies (ANA)
* [[Antinuclear antibodies]] (ANA)
* Antineutrophil cytoplasmic antibodies (ANCA)  
* [[Anti-neutrophil cytoplasmic antibodies]] (ANCA)  
* Antistreptolysin O antibodies (ASO)
* [[Antistreptococcal antibodies | Antistreptolysin O antibodies]] (ASO)


==References==
==References==
Line 31: Line 31:
[[Category:Signs and symptoms]]
[[Category:Signs and symptoms]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Primary care]]
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Primary care]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 20:03, 4 June 2013

Hematuria Microchapters

Home

Patient Information

Overview

Definition

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hematuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hematuria laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hematuria laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hematuria laboratory findings

CDC on Hematuria laboratory findings

Hematuria laboratory findings in the news

Blogs on Hematuria laboratory findings

Directions to Hospitals Treating Hematuria

Risk calculators and risk factors for Hematuria laboratory findings

Steven C. Campbell, M.D., Ph.D.

Laboratory Findings

Often, the diagnosis is made on the basis of the medical history and some blood tests—especially in young people in whom the risk of malignancy is negligible and the symptoms are generally self-limited.

A more complete evaluation would include the following:

References

Template:WH Template:WS